Enzyme replacement therapy for the treatment of Hunter disease: A systematic review with narrative synthesis and meta-analysis-Reference-Cited by-同舟云学术

Enzyme replacement therapy for the treatment of Hunter disease: A systematic review with narrative synthesis and meta-analysis

Published:2020-09 Issue:1-2 Volume:131 Page:206-210
ISSN:1096-7192
Container-title:Molecular Genetics and Metabolism
language:en
Short-container-title:Molecular Genetics and Metabolism

Author:

Wikman-Jorgensen Philip Erick,López Amorós Ana,Peris García Jorge,Esteve Atienzar Pedro Jesús,Cañizares Navarro Ruth,Asensio Tomás Maria Luisa,Seguí Ripoll Jose Miguel,Bonet David,Esteban-Giner María José,Robert Jaqueline,Giner-Galvañ Vicente

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference31 articles.

1. Development of idursulfase therapy for mucopolysaccharidosis type II(Hunter syndrome): the past, the present and the future;Whiteman;Drug Des. Devel. Ther.,2017

2. Phase I/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (hunter syndrome);Sohn;Orphanet J. Rare Dis.,2013

3. Presentation and treatments for Mucopolysaccharidosis type II (MPS II; Hunter syndrome);Stapleton;Expert Opin. Orphan Drug.,2017

4. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (hunter syndrome);Muenzer;Genet. Med.,2006

5. Genetics and gene therapy in hunter disease;Simona;Curr. Gene Ther.,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alterations of Plasmatic Biomarkers of Neurodegeneration in Mucopolysaccharidosis Type II Patients Under Enzyme Replacement Therapy;Cell Biochemistry and Biophysics;2023-07-20

2. Enzyme-Responsive Materials: Properties, Design, and Applications;ACS Symposium Series;2023-03-17

3. Results of 14-year-long Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II: Clinical Case;Current Pediatrics;2023-01-21

4. Effect of Anti-Iduronate 2-Sulfatase Antibodies in Patients with Mucopolysaccharidosis Type II Treated with Enzyme Replacement Therapy;The Journal of Pediatrics;2022-09

5. Clinical Case of Drug Allergy to Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II;Pediatric pharmacology;2022-07-12